Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
Foundation Medicine and InformedDNA® Collaborate to Improve Access to Genetic Counseling for Advanced Cancer Patients
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics